REXN News and Press, Rexahn Pharmaceuticals From 06/18/20

Rexahn Pharmaceuticals (NASDAQ: REXN ) has agreed to merge with privately held Ocuphire Pharma, a developer therapies for eye disorders, in an all-stock deal. More news on: Rexahn Pharmaceuticals, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read m...

Transaction to Create a Nasdaq-listed Biopharmaceutical Company Focused on Advancing Ocuphire’s Late-Stage Clinical Pipeline of Ophthalmic Drug Candidates $21.15 Million Investment Committed by Institutional Healthcare and Accredited Investors ROCKVILLE, Md. and FARMINGTON H...

Zosano Pharma (NASDAQ: ZSAN )  -47%  after pricing stock offering. More news on: Zosano Pharma Corporation, PolarityTE, Inc., PDS Biotechnology Corporation, Stocks on the move, , Read more ...

These Penny Stocks Are Hot Right Now; Will It Last? If you’re interested in making money with penny stocks , you’ll need to have a handle on risk. I think that’s safe to say for any type of investment. But for these cheap stocks, that risk is high but the rewards could be...

Gainers : Rexahn Pharmaceuticals (NASDAQ: REXN )  +85% . More news on: Rexahn Pharmaceuticals, Inc., Sprint Corporation, Genprex, Inc., Stocks on the move, , Read more ...

Thinly traded nano cap Rexahn Pharmaceuticals ( REXN +76.1% ) is up on a whopping 130x surge in volume in reaction to its out-license agreement with Zhejiang HaiChang Biotechnology Co., Ltd., for candidate RX-0201 and nano-liposomal formulations of RX-0201 named RX-0301 and RX-0047. Mo...

Sprint (NYSE: S ) +74%  after judge approves T-Mobile merger . More news on: Sprint Corporation, Rexahn Pharmaceuticals, Inc., ZK International Group Co., Ltd., Stocks on the move, Read more ...

Thinly traded nano cap Rexahn Pharmaceuticals ( REXN +52.4% ) is up on an 24x surge in volume, albeit on turnover of only 899K shares, in apparent response to encouraging preclinical data on pipeline candidate RX-5902. The results were just published in the journal Molecular Cancer Ther...

Gainers:  Rexahn Pharmaceuticals (NASDAQ: REXN ) +45% . California Resources Corporation (NYSE: CRC ) +40% . BeiGene (NASDAQ: BGNE ) +34% . El Pollo Loco Holdings (NASDAQ: LOCO ) +28% . Acorda Therapeutics (NASDAQ: ACOR ) +26% . American Axle & Manufacturing Holdings (NYSE: A...

ROCKVILLE, Md., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NasdaqCM: REXN) today announced that it has commenced a process to explore and evaluate strategic alternatives to enhance shareholder value. Rexahn has engaged Oppenheimer & Co., Inc. as its financial advis...